Economic impact of primary open-angle glaucoma in Australia
Background: Glaucoma is the World's leading cause of irreversible blindness, and poses serious public health and economic concerns. Design: Review. Samples: Published randomized trials and population‐based studies since 1985. Methods: We report the economic impact of primary open‐angle glau...
Gespeichert in:
| Veröffentlicht in: | Clinical & experimental ophthalmology 2011-09, Vol.39 (7), p.623-632 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 632 |
|---|---|
| container_issue | 7 |
| container_start_page | 623 |
| container_title | Clinical & experimental ophthalmology |
| container_volume | 39 |
| creator | Dirani, Mohamed Crowston, Jonathan G Taylor, Penny S Moore, Peter T Rogers, Sophie Pezzullo, M Lynne Keeffe, Jill E Taylor, Hugh R |
| description | Background: Glaucoma is the World's leading cause of irreversible blindness, and poses serious public health and economic concerns.
Design: Review.
Samples: Published randomized trials and population‐based studies since 1985.
Methods: We report the economic impact of primary open‐angle glaucoma and model the effect of changes in detection rates and management strategies.
Main Outcome Measures: The cost‐effectiveness of different interventions to prevent vision loss from primary open‐angle glaucoma was measured in terms of financial cost (Australian dollars) and disability‐adjusted life years.
Results: The prevalence of glaucoma in Australia is expected to increase from 208 000 in 2005 to 379 000 in 2025 because of the aging population. Health system costs over the same time period are estimated to increase from $AU355 million to $AU784 million. Total costs (health system costs, indirect costs and costs of loss of well‐being) will increase from $AU1.9 billion to $AU4.3 billion in Australia.
Conclusion: Primary open‐angle glaucoma poses a significant economic burden, which will increase substantially by 2025. This dynamic model provides a valuable tool for ongoing policy formulation and determining the economic impact of interventions to better prevent visual impairment and blindness from glaucoma. |
| doi_str_mv | 10.1111/j.1442-9071.2011.02530.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_959148745</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3072398691</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3850-e04e10c75c8455185161e6da56f93efd3fdfdd335d2f1f35713187a5a136f80d3</originalsourceid><addsrcrecordid>eNpdkE1PwkAQhjdGI4r-BdPEg6fWnf1qG-MBCOAHgQvG42Rtd0mxX7Y0wr-3FeTgXmaSed7NzEOIA9SD9t2vPRCCuSH1wWMUwKNMcuptT8jFcXB66JWgokcu63pNKZWMq3PSY6A4KBVekIdxVORFlkROkpU62jiFdcoqyXS1c4rS5K7OV6lxVqluoiLTTpI7g6beVDpN9BU5szqtzfWh9snbZLwcPbmzxfR5NJi5EQ8kdQ0VBmjkyygQUkIgQYFRsZbKhtzYmNvYxjHnMmYWLJc-cAh8LTVwZQMa8z652_9bVsVXY-oNZkkdmTTVuSmaGkMZggh8IVvy9h-5Lpoqb5dDEJwpGijGWurmQDUfmYnxcC_-WWmBxz3wnaRmd5wDxc4-rrETi51k7Ozjr33c4mi86Lo27-7zSb0x22NeV5-ofO5LfJ9PcfgKwXz5MsQJ_wFusISM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1432608622</pqid></control><display><type>article</type><title>Economic impact of primary open-angle glaucoma in Australia</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Dirani, Mohamed ; Crowston, Jonathan G ; Taylor, Penny S ; Moore, Peter T ; Rogers, Sophie ; Pezzullo, M Lynne ; Keeffe, Jill E ; Taylor, Hugh R</creator><creatorcontrib>Dirani, Mohamed ; Crowston, Jonathan G ; Taylor, Penny S ; Moore, Peter T ; Rogers, Sophie ; Pezzullo, M Lynne ; Keeffe, Jill E ; Taylor, Hugh R</creatorcontrib><description>Background: Glaucoma is the World's leading cause of irreversible blindness, and poses serious public health and economic concerns.
Design: Review.
Samples: Published randomized trials and population‐based studies since 1985.
Methods: We report the economic impact of primary open‐angle glaucoma and model the effect of changes in detection rates and management strategies.
Main Outcome Measures: The cost‐effectiveness of different interventions to prevent vision loss from primary open‐angle glaucoma was measured in terms of financial cost (Australian dollars) and disability‐adjusted life years.
Results: The prevalence of glaucoma in Australia is expected to increase from 208 000 in 2005 to 379 000 in 2025 because of the aging population. Health system costs over the same time period are estimated to increase from $AU355 million to $AU784 million. Total costs (health system costs, indirect costs and costs of loss of well‐being) will increase from $AU1.9 billion to $AU4.3 billion in Australia.
Conclusion: Primary open‐angle glaucoma poses a significant economic burden, which will increase substantially by 2025. This dynamic model provides a valuable tool for ongoing policy formulation and determining the economic impact of interventions to better prevent visual impairment and blindness from glaucoma.</description><identifier>ISSN: 1442-6404</identifier><identifier>EISSN: 1442-9071</identifier><identifier>DOI: 10.1111/j.1442-9071.2011.02530.x</identifier><identifier>PMID: 21631669</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Accidental Falls - economics ; Adult ; Aged ; Aged, 80 and over ; Antihypertensive Agents - economics ; Australia - epidemiology ; Cost-Benefit Analysis ; Costs ; Depressive Disorder - economics ; Diagnostic Techniques, Ophthalmological - economics ; economics ; Female ; Glaucoma ; Glaucoma, Open-Angle - economics ; Glaucoma, Open-Angle - therapy ; Health Care Costs ; Humans ; Laser Therapy - economics ; Male ; Middle Aged ; Prevalence ; Quality of Life ; Quality-Adjusted Life Years ; Risk Factors ; Studies ; Trabeculectomy - economics</subject><ispartof>Clinical & experimental ophthalmology, 2011-09, Vol.39 (7), p.623-632</ispartof><rights>2011 The Authors. Clinical and Experimental Ophthalmology © 2011 Royal Australian and New Zealand College of Ophthalmologists</rights><rights>2011 The Authors. Clinical and Experimental Ophthalmology © 2011 Royal Australian and New Zealand College of Ophthalmologists.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3850-e04e10c75c8455185161e6da56f93efd3fdfdd335d2f1f35713187a5a136f80d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1442-9071.2011.02530.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1442-9071.2011.02530.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21631669$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dirani, Mohamed</creatorcontrib><creatorcontrib>Crowston, Jonathan G</creatorcontrib><creatorcontrib>Taylor, Penny S</creatorcontrib><creatorcontrib>Moore, Peter T</creatorcontrib><creatorcontrib>Rogers, Sophie</creatorcontrib><creatorcontrib>Pezzullo, M Lynne</creatorcontrib><creatorcontrib>Keeffe, Jill E</creatorcontrib><creatorcontrib>Taylor, Hugh R</creatorcontrib><title>Economic impact of primary open-angle glaucoma in Australia</title><title>Clinical & experimental ophthalmology</title><addtitle>Clin Exp Ophthalmol</addtitle><description>Background: Glaucoma is the World's leading cause of irreversible blindness, and poses serious public health and economic concerns.
Design: Review.
Samples: Published randomized trials and population‐based studies since 1985.
Methods: We report the economic impact of primary open‐angle glaucoma and model the effect of changes in detection rates and management strategies.
Main Outcome Measures: The cost‐effectiveness of different interventions to prevent vision loss from primary open‐angle glaucoma was measured in terms of financial cost (Australian dollars) and disability‐adjusted life years.
Results: The prevalence of glaucoma in Australia is expected to increase from 208 000 in 2005 to 379 000 in 2025 because of the aging population. Health system costs over the same time period are estimated to increase from $AU355 million to $AU784 million. Total costs (health system costs, indirect costs and costs of loss of well‐being) will increase from $AU1.9 billion to $AU4.3 billion in Australia.
Conclusion: Primary open‐angle glaucoma poses a significant economic burden, which will increase substantially by 2025. This dynamic model provides a valuable tool for ongoing policy formulation and determining the economic impact of interventions to better prevent visual impairment and blindness from glaucoma.</description><subject>Accidental Falls - economics</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antihypertensive Agents - economics</subject><subject>Australia - epidemiology</subject><subject>Cost-Benefit Analysis</subject><subject>Costs</subject><subject>Depressive Disorder - economics</subject><subject>Diagnostic Techniques, Ophthalmological - economics</subject><subject>economics</subject><subject>Female</subject><subject>Glaucoma</subject><subject>Glaucoma, Open-Angle - economics</subject><subject>Glaucoma, Open-Angle - therapy</subject><subject>Health Care Costs</subject><subject>Humans</subject><subject>Laser Therapy - economics</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prevalence</subject><subject>Quality of Life</subject><subject>Quality-Adjusted Life Years</subject><subject>Risk Factors</subject><subject>Studies</subject><subject>Trabeculectomy - economics</subject><issn>1442-6404</issn><issn>1442-9071</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkE1PwkAQhjdGI4r-BdPEg6fWnf1qG-MBCOAHgQvG42Rtd0mxX7Y0wr-3FeTgXmaSed7NzEOIA9SD9t2vPRCCuSH1wWMUwKNMcuptT8jFcXB66JWgokcu63pNKZWMq3PSY6A4KBVekIdxVORFlkROkpU62jiFdcoqyXS1c4rS5K7OV6lxVqluoiLTTpI7g6beVDpN9BU5szqtzfWh9snbZLwcPbmzxfR5NJi5EQ8kdQ0VBmjkyygQUkIgQYFRsZbKhtzYmNvYxjHnMmYWLJc-cAh8LTVwZQMa8z652_9bVsVXY-oNZkkdmTTVuSmaGkMZggh8IVvy9h-5Lpoqb5dDEJwpGijGWurmQDUfmYnxcC_-WWmBxz3wnaRmd5wDxc4-rrETi51k7Ozjr33c4mi86Lo27-7zSb0x22NeV5-ofO5LfJ9PcfgKwXz5MsQJ_wFusISM</recordid><startdate>201109</startdate><enddate>201109</enddate><creator>Dirani, Mohamed</creator><creator>Crowston, Jonathan G</creator><creator>Taylor, Penny S</creator><creator>Moore, Peter T</creator><creator>Rogers, Sophie</creator><creator>Pezzullo, M Lynne</creator><creator>Keeffe, Jill E</creator><creator>Taylor, Hugh R</creator><general>Blackwell Publishing Asia</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201109</creationdate><title>Economic impact of primary open-angle glaucoma in Australia</title><author>Dirani, Mohamed ; Crowston, Jonathan G ; Taylor, Penny S ; Moore, Peter T ; Rogers, Sophie ; Pezzullo, M Lynne ; Keeffe, Jill E ; Taylor, Hugh R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3850-e04e10c75c8455185161e6da56f93efd3fdfdd335d2f1f35713187a5a136f80d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Accidental Falls - economics</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antihypertensive Agents - economics</topic><topic>Australia - epidemiology</topic><topic>Cost-Benefit Analysis</topic><topic>Costs</topic><topic>Depressive Disorder - economics</topic><topic>Diagnostic Techniques, Ophthalmological - economics</topic><topic>economics</topic><topic>Female</topic><topic>Glaucoma</topic><topic>Glaucoma, Open-Angle - economics</topic><topic>Glaucoma, Open-Angle - therapy</topic><topic>Health Care Costs</topic><topic>Humans</topic><topic>Laser Therapy - economics</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prevalence</topic><topic>Quality of Life</topic><topic>Quality-Adjusted Life Years</topic><topic>Risk Factors</topic><topic>Studies</topic><topic>Trabeculectomy - economics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dirani, Mohamed</creatorcontrib><creatorcontrib>Crowston, Jonathan G</creatorcontrib><creatorcontrib>Taylor, Penny S</creatorcontrib><creatorcontrib>Moore, Peter T</creatorcontrib><creatorcontrib>Rogers, Sophie</creatorcontrib><creatorcontrib>Pezzullo, M Lynne</creatorcontrib><creatorcontrib>Keeffe, Jill E</creatorcontrib><creatorcontrib>Taylor, Hugh R</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical & experimental ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dirani, Mohamed</au><au>Crowston, Jonathan G</au><au>Taylor, Penny S</au><au>Moore, Peter T</au><au>Rogers, Sophie</au><au>Pezzullo, M Lynne</au><au>Keeffe, Jill E</au><au>Taylor, Hugh R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Economic impact of primary open-angle glaucoma in Australia</atitle><jtitle>Clinical & experimental ophthalmology</jtitle><addtitle>Clin Exp Ophthalmol</addtitle><date>2011-09</date><risdate>2011</risdate><volume>39</volume><issue>7</issue><spage>623</spage><epage>632</epage><pages>623-632</pages><issn>1442-6404</issn><eissn>1442-9071</eissn><abstract>Background: Glaucoma is the World's leading cause of irreversible blindness, and poses serious public health and economic concerns.
Design: Review.
Samples: Published randomized trials and population‐based studies since 1985.
Methods: We report the economic impact of primary open‐angle glaucoma and model the effect of changes in detection rates and management strategies.
Main Outcome Measures: The cost‐effectiveness of different interventions to prevent vision loss from primary open‐angle glaucoma was measured in terms of financial cost (Australian dollars) and disability‐adjusted life years.
Results: The prevalence of glaucoma in Australia is expected to increase from 208 000 in 2005 to 379 000 in 2025 because of the aging population. Health system costs over the same time period are estimated to increase from $AU355 million to $AU784 million. Total costs (health system costs, indirect costs and costs of loss of well‐being) will increase from $AU1.9 billion to $AU4.3 billion in Australia.
Conclusion: Primary open‐angle glaucoma poses a significant economic burden, which will increase substantially by 2025. This dynamic model provides a valuable tool for ongoing policy formulation and determining the economic impact of interventions to better prevent visual impairment and blindness from glaucoma.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>21631669</pmid><doi>10.1111/j.1442-9071.2011.02530.x</doi><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1442-6404 |
| ispartof | Clinical & experimental ophthalmology, 2011-09, Vol.39 (7), p.623-632 |
| issn | 1442-6404 1442-9071 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_959148745 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Accidental Falls - economics Adult Aged Aged, 80 and over Antihypertensive Agents - economics Australia - epidemiology Cost-Benefit Analysis Costs Depressive Disorder - economics Diagnostic Techniques, Ophthalmological - economics economics Female Glaucoma Glaucoma, Open-Angle - economics Glaucoma, Open-Angle - therapy Health Care Costs Humans Laser Therapy - economics Male Middle Aged Prevalence Quality of Life Quality-Adjusted Life Years Risk Factors Studies Trabeculectomy - economics |
| title | Economic impact of primary open-angle glaucoma in Australia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T20%3A29%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Economic%20impact%20of%20primary%20open-angle%20glaucoma%20in%20Australia&rft.jtitle=Clinical%20&%20experimental%20ophthalmology&rft.au=Dirani,%20Mohamed&rft.date=2011-09&rft.volume=39&rft.issue=7&rft.spage=623&rft.epage=632&rft.pages=623-632&rft.issn=1442-6404&rft.eissn=1442-9071&rft_id=info:doi/10.1111/j.1442-9071.2011.02530.x&rft_dat=%3Cproquest_pubme%3E3072398691%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1432608622&rft_id=info:pmid/21631669&rfr_iscdi=true |